Skip to main content
Sign In
 

Lee S. Newman, MD, MA - Professor

Department of Environmental and Occupational Health And Department of Epidemiology


1975 BA    Amherst College, Amherst, MA

1977 MA    Cornell University, Ithaca, NY (Social Psychology)

1980 MD   Vanderbilt University School of Medicine, Nashville, TN

1980-1983 Intern/Resident Vanderbilt University School of Medicine, Nashville, TN (Internal Medicine)

1984-1987 Fellowship University of Colorado School of Medicine, Denver, CO (Pulmonary Science)

Areas of Clinical Interest:

For the past 20 years, Dr. Newman’s clinical practice has focused on occupational lung disorders and granulomatous lung disorders including sarcoidosis and chronic beryllium disease. He consults nationally and internationally to government, industry and labor organizations on occupational and environmental health.

 

Clinic Location:

Dr. Newman does not currently see patients at UCD. He provides consultation regarding environmental and occupational health to communities, industry, labor, and government agencies.

Director of the CDC/NIOSH Mountain and Plains Education and Research Center (for occupational and environmental health)

Co-Director of the Occupational and Environmental Medicine Residency Program

Immunology and immunotoxicology laboratory mentoring

Occupational Epidemiology mentoring

Graduate teaching: Introduction to Environmental and Occupational Health; Environmental and Occupational Toxicology

Occupational lung and allergic disorders, sarcoidosis, chronic beryllium disease and other granulomatous diseases; health effects of exposures in energy, natural gas, and nuclear weapon industries; utility of health informatics in the occupational health setting; pulmonary immunology, immunotoxicology, including cytokine gene regulation by beryllium, T cell receptor x antigen presenting cell interaction.


Research Team:

Brian Tooker

Stephen Brindley, MS

Rossman, M.D., Thompson, B., Fredrick, M., Iannuzzi, M.C., Rybicki, B.A., Pandey, J.P., Newman, L.S., Rose, C., Magira, E., Monos, D., ACCESS Group.  HLA and environmental interactions in sarcoidosis. Sarcoid Vasc Diff Lung Dis 2008 25:125-32.

Mroz, M.M., Maier, L.A., Strand, M., Silviera, L., Newman, L.S.  Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease.  Am J Indust Med 2009 52:762-73. 

Dobis, D.R., Sawyer, R.T., Gillespie, M.M., Newman, L.S., Maier, L.A., Day, B.J.  Sulfasalazine and Mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production. Am J Respir Cell Mol Biol 2009 (Epub ahead of print). 

Oswald-Richter, K., Sato, H., Hajizadeh, R., Shepherd, B.E., Sidney, J., Sette, A., Newman, L.S., Drake, W.P.  Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele DRB1*1101.  J Clin Immunol 2010:157-66. 

Sato, H., Silveira, L., Spagnolo, P., Gillespie, M., Gottschall, E.B., Welsh, K.I., du Bois, R.M., Newman, L.S., Maier, L.A.  C-C chemokine receptor 5 (CCR5) polymorphisms in beryllium disease.  Eur Respir J 2010 (Epub ahead of print). 

Weaver, D.R., Newman, L.S., Lezotte, D.C., Morley, P.S.  Perceptions regarding workplace hazards at a veterinary referral and teaching hospital.  J Am Vet Med Assoc 2009 (in press).